Background Shared decision-making (SDM), a process whereby physicians and patients
collaborate to select interventions, is not well understood for biologic treatment of …

Background: We assessed cost–effectiveness of insertable cardiac monitors (ICMs) in a US
cryptogenic stroke population. Materials & methods: We modelled lifetime costs and quality …

Background Guidelines recommend a confirmed diagnosis of atrial fibrillation (AF) to initiate
oral anticoagulation in cryptogenic stroke (CS) patients. However, the intermittent nature of …

Objective Prevention of recurrent stroke in patients with embolic stroke of undetermined
source (ESUS) is challenging. The advent of safer anticoagulation in the form of direct oral …

Background Integrating patient-specific cardiac implantable electronic device (CIED)-
detected atrial fibrillation (AF) burden with measures of health care cost and utilization …

Diagnosing cardiac pauses that could produce syncopal episodes is important to guide
appropriate therapy. However, the infrequent nature of these episodes can make detection …

Background Detection of atrial fibrillation (AF) in patients with embolic stroke of
undetermined source (ESUS) is challenging due to its paroxysmal nature. We sought to …

Background Compared with short-term electrocardiogram (ECG) monitors, insertable
cardiac monitors (ICMs) have been shown to increase atrial fibrillation (AF) detection rates …

Introduction Early use of insertable cardiac monitor (ICM) is recommended for patients with
unexplained syncope following initial clinical workup, due to its superior ability to establish …

Abstract Background Insertable cardiac monitors (ICMs) are a clinically effective means of
detecting atrial fibrillation (AF) in high-risk patients, and guiding the initiation of non-vitamin …